India-Israel Jointly Conducting Trials On Technologies To Detect COVID-19 In 30 Seconds
New Delhi: There are possibilities that breath analyser and a voice test may detect Covid-19 in about 30 seconds, according to the statement of an Israeli officials.
Israel and India are conducting trials here on a large sample of patients for four different kinds of technologies that have the potential to detect COVID-19 in about 30 seconds. Israeli Ambassador to India Ron Malka on Friday visited the special testing site created at the Dr Ram Manohar Lohia (RML) Hospital to witness the ongoing trials being conducted since the last three days for rapid COVID-19 testing, the Israeli release on his visit said.
Trials begin for rapid #COVID19 testing in under 30 seconds. Ambassador @DrRonMalka & @PrinSciAdvGoI visited Dr Ram Manohar Lohia Hospital today to witness the first trials of the testing, jointly being developed by 🇮🇱🇮🇳. We hope that significant progress will be made soon. pic.twitter.com/mef17O1Ww8
— Israel in India (@IsraelinIndia) July 31, 2020
The rapid testing is being jointly developed in cooperation with the Defense Research and Development Directorate of the Israeli Ministry of Defence, India’s Defence Research and Development Organisation, Council of Scientific and Industrial Research and Principal Scientific Advisor, India — coordinated by the ministries of foreign affairs of Israel and India.
— Israel in India (@IsraelinIndia) July 29, 2020
RML hospital is one of the testing sites which has started trials of four different kinds of technologies that have the potential to detect coronavirus in as less as 30 seconds,” the statement said.
How Technology Works?
These simple, non-invasive technologies include a voice test that uses artificial intelligence to identify changes in the patient’s voice and a breath analyser test which requires the patient to blow into a tube and it detects the virus using terra-hertz waves, it said. There is also isothermal testing that enables identification of the coronavirus in a saliva sample and a test using polyamino acids that seeks to isolate proteins related to COVID-19, the statement said.
“These trials are being conducted on a large sample of patients in India and if the results validate the effectiveness of the tests, they would be mass manufactured in India and marketed to the world by Israel and India jointly,” it said.
These trials are a part of a multi-pronged mission visiting India from Israel to cooperate on COVID-19 research and development, further cementing the strategic relationship between the two nations, the statement said.